Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Placing

28 Jan 2016 07:00

RNS Number : 2322N
FastForward Innovations Limited
28 January 2016
 

For immediate release

28 January 2016

FastForward Innovations Limited

("FastForward" or the "Company")

Placing

Director Dealing

Further to the announcement by FastForward Innovations Limited (AIM: FFWD) on 11 January 2016, the Company is pleased to announce that it has today agreed to place 37,426,901new Ordinary Shares of 1p each (the "Placing Shares") at a price of 15p per Placing Share with a number of new and existing investors thereby raising US$8 million(£5,614,035 at an exchange rate of £1:US$1.425, being the rate on the date the Company determined the terms of the placing)before expenses (the "Placing"). The proceeds of the Placing will be used to assist the Company in making investments in accordance with its investing policy and for general working capital purposes.

In accordance with the terms of subscription letters signed by investors, payment for the Placing Shares is due by 5 February 2016. Subject to payment, application for the Placing Shares (which will rank paripassu with the existing Ordinary Shares) to be admitted to trading on AIM ("Admission") will be made with dealings expected to commence at 8.00 a.m. on 11 February2016.

 

The Company expects that the enlarged issued share capital following the issue of the Placing Shares will be 134,108,445Ordinary Shares (the "Enlarged Issued Share Capital").

Commenting on the Placing, Chief Executive Officer Mr.Lorne Abony noted:

"I am delighted to close the Placing today at a premium to our market price. The Placing was significantly over-subscribed. The fact that the Placing was over-subscribed is a very positive indicator for FFWD, given the global market conditions and the fact that we did not offer this placing to institutional investors. In addition,we are pleased to note a number of high profile placees, well known in the market as "smart money" investors, including Gigi Levy-Weiss, Norbert Teufelberger, Jim Mellon, Stephen Dattels and Russell Geyser; all of whom I believe will add considerably to FastForward as it grows its capital base and investment pipeline over the coming months."

Related Party Transaction

Mr Lorne Abony, Mr Stephen Dattels and Mr Jim Mellon(who are each Directors of the Company) have participated in the Placing. The participation of the Directors is as set out below:

Name

Subscription

Placing Shares

Total Ordinary Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Lorne Abony1

US$1,215,000

5,684,211

26,438,391

19.71%

Stephen Dattels2

US$500,000

2,339,181

15,209,248

11.34%

Jim Mellon3

US$250,000

1,169,591

10,425,991

7.77%

1 Lorne Abony's interest in shares is held by Abony Enterprises Limited Partnership, a limited partnership of which he is the majority legal owner.

2 Mr Dattels' interest in shares is held by Regent Mercantile Holdings Limited, a company owned by a trust under which Mr Dattels is a discretionary beneficiary. Mr Ian Burns is a director of Regent Mercantile Holdings Limited.

3 Mr Mellon's interest in shares is held by Galloway Limited, a company owned by a trust of which Mr James Mellon is a life tenant.

The Directors are related parties for the purposes of the AIM Rules. In addition, Mr Ian Burns is a director of Regent Mercantile Holdings Limited so is also regarded as a related party for the purposes of the Placing. The participation of the three Directorsin the Placing constitutes a Related Party Transaction under Rule 13 of the AIM Rules for Companies.

Accordingly, Mr Bryan Smith, the independent director of the Company for the purposes of the Placing, confirms that, having consulted with the Company's Nominated Adviser, the terms of the Placing are fair and reasonable insofar as the Company's shareholders are concerned. In particular Mr Smith notes that the Directors have participated on the same terms as all other placees and that the Placing is at a premium to the current market price.

The Investors

In addition to Mr Abony, Mr Mellon and Mr Dattels, following the issue of the Placing Shares the following shareholders will be interested in more than 3 per cent. ofthe Enlarged Issued Share Capital:

Name

Subscription

Placing Shares

Total Ordinary Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Russell Geyser

US$2,000,000

9,356,725

12,641,876

9.43%

Mr Norbert Teufelberger

US$1,000,000

4,678,363

8,784,802

6.55%

Gigi Levy-Weiss

US$1,050,000

4,678,363

4,678,363

3.49%

Issued Shares

Following Admission of the Placing Shares,the Company's enlarged issued share capital will consist of 134,108,445Ordinary Shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit www.fstfwd.coor contact:

James Biddle/ Michael Cornish (Nomad)

Beaumont Cornish LimitedTel: +44 207 628 3396

 

Peterhouse Corporate Finance Limited

Guy Miller/ Lucy Williams

Tel: +44 (0) 207 469 0930

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

DISCLAIMER

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as Nominated adviser to FastForward Innovations Limited and no one else in connection with the Placing and will not be responsible to anyone other than FastForward Innovations Limited for providing the protections afforded to clients of Beaumont Cornish Limited nor for providing advice in relation to the Placing. Neither Beaumont Cornish Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Beaumont Cornish Limited in connection with this Announcement, any statement contained herein, or otherwise.

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForwardInnovations Limited. There can be no assurance that such statements will prove to be accurate, achievable or recognisable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForwardInnovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCGDBUXDBGLR
Date   Source Headline
6th Apr 20167:00 amRNSInvestee Company Update
5th Apr 20162:50 pmRNSInvestee Company Update
4th Apr 20167:00 amRNSInvestee Company Update: Schoold
31st Mar 20161:18 pmRNSInvestee Company Update
9th Mar 201610:00 amRNSExpected announcement date of 2016 Final Results
4th Mar 201610:01 amRNSInvestee Company Update
3rd Mar 20165:15 pmRNSInvestee Company Update: Vemo
19th Feb 20167:00 amRNSGrant of Options
18th Feb 20168:21 amRNSHolding(s) in Company
15th Feb 20165:23 pmRNSTransaction in Own Shares
15th Feb 20161:26 pmRNSFurther Investment in Yooya
12th Feb 20165:19 pmRNSCompletion Placing
8th Feb 20166:20 pmRNSPlacing Update
2nd Feb 20167:00 amRNSInvestee Company Update
28th Jan 20167:00 amRNSPlacing
27th Jan 20164:47 pmRNSLorne Abony Appointed as Chief Executive Officer
26th Jan 20167:00 amRNSInvestment
11th Jan 20164:27 pmRNSHolding(s) in Company
11th Jan 201612:33 pmRNSInvestment in Yooya Media
6th Jan 20161:47 pmRNSDirectorate Change
5th Jan 20165:19 pmRNSCompletion of investment in VEMO and Placing
29th Dec 20157:00 amRNSNew Website
22nd Dec 20153:08 pmRNSPlacing and Director Dealing
21st Dec 20155:56 pmRNSAcquisition of shares in Vemo Education, Inc
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
17th Dec 20157:00 amRNSInvestee Company Update - Vemo Education Inc
2nd Dec 20154:26 pmRNSHolding(s) in Company
26th Nov 201511:02 amRNSPlacing
25th Nov 20157:00 amRNSInvestee Company Update - Vemo Education Inc
23rd Nov 20156:05 pmRNSHolding(s) in Company
23rd Nov 201511:36 amRNSResult of General Meeting
23rd Nov 20157:00 amRNSAcquisition
13th Nov 20157:00 amRNSHalf Yearly Report
10th Nov 20151:32 pmRNSPlacing
3rd Nov 20157:00 amRNSProposed Name Change
29th Oct 20157:00 amRNSCorporate Update
22nd Oct 20153:35 pmRNSInvestee company Intensity Therapeutics update
14th Oct 20157:53 amRNSInvestment in Factom
6th Oct 20158:03 amRNSInvestment in Intensity Therapeutics Inc
21st Sep 20157:00 amRNS10% Acquired of nanopayment developer SatoshiPay
18th Sep 201510:32 amRNSResult of AGM
8th Sep 20157:00 amRNSIssue of Equity
7th Sep 20157:00 amRNSAcquisition
1st Sep 20157:03 amRNSIssue of Equity
31st Jul 20158:24 amRNSUpdate on Investment review
28th Jul 201511:36 amRNSResult of EGM
13th Jul 20158:00 amRNSChange of Investing Policy and Name
13th Jul 20157:00 amRNSDirectorate Change
23rd Jun 20152:36 pmRNSNotice of AGM
17th Jun 20159:34 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.